1,289
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Natural gum as mucoadhesive controlled release carriers: evaluation of Cefpodoxime Proxetil by D-Optimal design technique

&
Pages 118-129 | Received 12 May 2013, Accepted 05 Aug 2013, Published online: 13 Sep 2013

Figures & data

Figure 1. (a) FTIR spectrum of Cefpodoxime Proxetil; (b) FTIR spectrum of drug–excipients mixture; (c) FTIR spectrum of excipients mixture.

Figure 1. (a) FTIR spectrum of Cefpodoxime Proxetil; (b) FTIR spectrum of drug–excipients mixture; (c) FTIR spectrum of excipients mixture.

Figure 2. (a) DSC thermogram of Cefpodoxime Proxetil; (b) DSC thermogram of drug–excipients mixture.

Figure 2. (a) DSC thermogram of Cefpodoxime Proxetil; (b) DSC thermogram of drug–excipients mixture.

Figure 3. In vitro dissolution of Cefpodoxime Proxetil mucoadhesive tablets (S1 to S9).

Figure 3. In vitro dissolution of Cefpodoxime Proxetil mucoadhesive tablets (S1 to S9).

Figure 4. In vitro dissolution of Cefpodoxime Proxetil mucoadhesive tablets (C1 to C9).

Figure 4. In vitro dissolution of Cefpodoxime Proxetil mucoadhesive tablets (C1 to C9).

Table 1. Composition of Cefpodoxime Proxetil mucoadhesive tablets (S1–S9).

Table 2. Composition of Cefpodoxime Proxetil mucoadhesive tablets (C1–C9).

Table 3. Evaluation of powder blend of Cefpodoxime Proxetil mucoadhesive tablets (S1–S9).

Table 4. Evaluation of powder blend of Cefpodoxime Proxetil mucoadhesive tablets (C1–C9).

Table 5. Evaluation parameters of Cefpodoxime Proxetil mucoadhesive tablets (S1–S9).

Table 6. Evaluation parameters of Cefpodoxime Proxetil mucoadhesive tablets (C1–C9).

Figure 5. Response surface plots for (a) T4; (b) T8; (c) T12.

Figure 5. Response surface plots for (a) T4; (b) T8; (c) T12.

Figure 6. Swelling index of Cefpodoxime Proxetil mucoadhesive tablets (S1 to S9).

Figure 6. Swelling index of Cefpodoxime Proxetil mucoadhesive tablets (S1 to S9).

Figure 7. Swelling index of Cefpodoxime Proxetil mucoadhesive tablets (C1 to C9).

Figure 7. Swelling index of Cefpodoxime Proxetil mucoadhesive tablets (C1 to C9).

Figure 8. X-ray photographs of Cefpodoxime Proxetil mucoadhesive tablets at different time intervals. (a) at 0 h; (b) after 2 h; (c) after 4 h; (d) after 6 h; (e) after 8 h; (f) after 10 h.

Figure 8. X-ray photographs of Cefpodoxime Proxetil mucoadhesive tablets at different time intervals. (a) at 0 h; (b) after 2 h; (c) after 4 h; (d) after 6 h; (e) after 8 h; (f) after 10 h.

Table 7. Evaluation of Cefpodoxime Proxetil mucoadhesive tablets (S7) kept for stability at 40 °C/75% relative humidity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.